GEC-ESTRO 头颈癌近距离放射治疗（介入放射治疗）建议：第二次更新，重点关注 HDR 和 PDR。

IF 4.9 1区医学 Q1 ONCOLOGY

Radiotherapy and Oncology Pub Date : 2024-09-14 DOI:10.1016/j.radonc.2024.110533

J.L. Guinot , W. Bacorro , A. Budrukkar , F. Bussu , V. Gonzalez-Perez , R. Jaberi , R. Martinez-Monge , A. Rembielak , A. Rovirosa , V. Strnad , Z. Takácsi-Nagy , L. Tagliaferri , the Head & Neck and Skin Working Group of GEC-ESTRO

{"title":"GEC-ESTRO 头颈癌近距离放射治疗（介入放射治疗）建议：第二次更新，重点关注 HDR 和 PDR。","authors":"J.L. Guinot , W. Bacorro , A. Budrukkar , F. Bussu , V. Gonzalez-Perez , R. Jaberi , R. Martinez-Monge , A. Rembielak , A. Rovirosa , V. Strnad , Z. Takácsi-Nagy , L. Tagliaferri , the Head & Neck and Skin Working Group of GEC-ESTRO","doi":"10.1016/j.radonc.2024.110533","DOIUrl":null,"url":null,"abstract":"<div><div>Modern brachytherapy (BT) is playing an important role in the multidisciplinary treatment of Head and Neck (H&N) cancer, as an organ- and function-preserving therapy. Low-dose-rate (LDR) technology has been replaced by modern remote afterloading and stepping source equipment using pulsed dose rate (PDR) or high dose rate (HDR) sources, improved image guidance and 3D treatment planning systems. This is an update of the previous GEC-ESTRO recommendations for H&N tumors, mainly applied to squamous carcinomas. Indications, results and recommended doses for different tumor sites are presented according to the published studies.</div></div>","PeriodicalId":21041,"journal":{"name":"Radiotherapy and Oncology","volume":"201 ","pages":"Article 110533"},"PeriodicalIF":4.9000,"publicationDate":"2024-09-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"GEC-ESTRO recommendations for head & neck cancer brachytherapy (interventional radiotherapy): 2nd update with focus on HDR and PDR\",\"authors\":\"J.L. Guinot , W. Bacorro , A. Budrukkar , F. Bussu , V. Gonzalez-Perez , R. Jaberi , R. Martinez-Monge , A. Rembielak , A. Rovirosa , V. Strnad , Z. Takácsi-Nagy , L. Tagliaferri , the Head & Neck and Skin Working Group of GEC-ESTRO\",\"doi\":\"10.1016/j.radonc.2024.110533\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Modern brachytherapy (BT) is playing an important role in the multidisciplinary treatment of Head and Neck (H&N) cancer, as an organ- and function-preserving therapy. Low-dose-rate (LDR) technology has been replaced by modern remote afterloading and stepping source equipment using pulsed dose rate (PDR) or high dose rate (HDR) sources, improved image guidance and 3D treatment planning systems. This is an update of the previous GEC-ESTRO recommendations for H&N tumors, mainly applied to squamous carcinomas. Indications, results and recommended doses for different tumor sites are presented according to the published studies.</div></div>\",\"PeriodicalId\":21041,\"journal\":{\"name\":\"Radiotherapy and Oncology\",\"volume\":\"201 \",\"pages\":\"Article 110533\"},\"PeriodicalIF\":4.9000,\"publicationDate\":\"2024-09-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Radiotherapy and Oncology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0167814024035114\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Radiotherapy and Oncology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0167814024035114","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}

引用次数: 0

摘要

现代近距离放射治疗（BT）作为一种保留器官和功能的疗法，在头颈部（H&N）癌症的多学科治疗中发挥着重要作用。低剂量率（LDR）技术已被使用脉冲剂量率（PDR）或高剂量率（HDR）源、改进的图像引导和三维治疗计划系统的现代远程后装和步进源设备所取代。这是 GEC-ESTRO 先前对 H&N 肿瘤建议的更新，主要适用于鳞状癌。根据已发表的研究，介绍了不同肿瘤部位的适应症、结果和推荐剂量。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

GEC-ESTRO recommendations for head & neck cancer brachytherapy (interventional radiotherapy): 2nd update with focus on HDR and PDR

Modern brachytherapy (BT) is playing an important role in the multidisciplinary treatment of Head and Neck (H&N) cancer, as an organ- and function-preserving therapy. Low-dose-rate (LDR) technology has been replaced by modern remote afterloading and stepping source equipment using pulsed dose rate (PDR) or high dose rate (HDR) sources, improved image guidance and 3D treatment planning systems. This is an update of the previous GEC-ESTRO recommendations for H&N tumors, mainly applied to squamous carcinomas. Indications, results and recommended doses for different tumor sites are presented according to the published studies.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Radiotherapy and Oncology 医学-核医学

CiteScore

10.30

自引率

10.50%

发文量

2445

审稿时长

45 days

期刊介绍： Radiotherapy and Oncology publishes papers describing original research as well as review articles. It covers areas of interest relating to radiation oncology. This includes: clinical radiotherapy, combined modality treatment, translational studies, epidemiological outcomes, imaging, dosimetry, and radiation therapy planning, experimental work in radiobiology, chemobiology, hyperthermia and tumour biology, as well as data science in radiation oncology and physics aspects relevant to oncology.Papers on more general aspects of interest to the radiation oncologist including chemotherapy, surgery and immunology are also published.